A study to evaluate the effect of improving makers for oxidative stress and blood vessel elasticity in healthy adults by ingestion of Wasabi-sulfinyl(R) containing foods.

A study to evaluate the effect of improving makers for oxidative stress and blood vessel elasticity in healthy adults by ingestion of Wasabi-sulfinyl(R) containing foods. - A study to evaluate the effect of improving makers for oxidative stress and blood vessel elasticity by ingestion of Wasabi-sulfinyl(R) containing foods.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000027401

Enrollment

Registered

2018-10-13

Start date

2017-05-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

Ingestion of Wasabi-sulfinyl(R) containing foods for 12 weeks Ingestion of placebo for 12 weeks

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) Males and females aged 20 to less than 65 years old. (2) Those who have feeling of fatigue at screening. (3) Those who have consciousness that sleep is not sufficient at screening. (4) Those who have a lower anti-oxidant potential at screening.

Exclusion criteria

Exclusion criteria: (1) Use of product affecting the data of this study, such as medicine, food for specified health use, supplement, diet food. (2) With allergy to the study foods. (3) Subjects who has a disease under treatment. (4) Subjects who has under treatment or a history of serious disease (e.g., diabetes, liver disease, kidney disease, heart disease or cancer). (5) Subjects who are judged as unsuitable for the study based on the results of clinical and physical examination. (6) Subjects who are alcohol consumption ( more than 60g/day) / subjects who are excess smorker ( more than 21/day). (7) Subjects who have habits affecting research results, such as doing shift work day and night, or Subjects who have a plan that affect research results such as day and night shift work and overseas. (8) Subjects who have participated in other clinical study within the last one month prior to the current study. (9) Subjects who are planned to become pregnant after informed consent for the current study or are pregnant or lactating. (10) Subjects who are judged as unsuitable for the study based on the results of lifestyle questionnaire. (11) Subjects who are judged as unsuitable by doctor for other reasons.

Design outcomes

Primary

Measure	Time frame
d-ROMs, BAP, anti-oxidant potential, MDA-LDL, LPO	—

Secondary

Measure	Time frame
baPWV, blood flow, hs-CRP, Fatigue sensation (VAS), skin questionnaire, AIS, PSQI-j	—

Countries

Japan

Contacts

Public ContactShingo Yamamichi

TTC Co.,Ltd Clinical Research Planning Department

s.yamamichi@ttc-tokyo.co.jp03-5459-5329

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026